Beryl Drugs Ltd.
BSE: 524606 | Sector: Health care |
NSE: N.A. | ISIN Code: INE415H01017 |
BSE 15:16 | 27 Jun | 8.48 |
0.16 (1.92%) |
OPEN
8.70 |
HIGH
8.70 |
LOW
8.48 |
NSE 05:30 | 01 Jan | Beryl Drugs Ltd |
OPEN | 8.70 |
PREVIOUS CLOSE | 8.32 |
VOLUME | 916 |
52-Week high | 19.30 |
52-Week low | 7.50 |
P/E | |
Mkt Cap.(Rs cr) | 4 |
Buy Price | 8.05 |
Buy Qty | 500.00 |
Sell Price | 8.48 |
Sell Qty | 147.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Beryl Drugs Ltd. (BERYLDRUGS) - Nine Monthly Result
Particulars (![]() |
Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 |
Net Sales/Income From Operations | 11.25 | 8.61 | 9.94 | 10.79 | 11.76 |
Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.46 |
Total Income | 11.25 | 8.61 | 9.94 | 10.79 | 12.22 |
Total Expenditure | 10.39 | 7.21 | 8.57 | 9.70 | 11.05 |
Operating Profit | 0.86 | 1.39 | 1.37 | 1.10 | 1.16 |
Interest | 0.34 | 0.32 | 0.18 | 0.17 | 0.09 |
Gross Profit | 0.52 | 1.07 | 1.18 | 0.92 | 1.07 |
Depreciation | 0.82 | 1.04 | 0.41 | 0.21 | 0.30 |
PBT | -0.29 | 0.03 | 0.78 | 0.72 | 0.77 |
Tax | 0.00 | 0.05 | 0.13 | 0.18 | 0.09 |
Net Profit/(Loss) | -0.18 | 0.12 | 0.57 | 0.49 | 0.68 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 |
Profit After Exceptional Items | -0.18 | 0.12 | 0.57 | 0.49 | 0.27 |
Equity Share Capital | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | -0.36 | 0.24 | 1.12 | 0.96 | 1.34 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Beryl Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices